Skip to content

13F-HR filed by MPM BIOIMPACT LLC

MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-12, with 11 holding rows worth $376,117,000.

Accession
0000950123-20-008310
Filed
2020-08-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 11 entries on the cover page, a total value of $376,117,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $376,116,000 with VALUE read as thousands by filing date, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REPARE THERAPEUTICS INC760273102COM2,388,337$74,086,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM3,898,422$64,714,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM3,370,982$51,778,000thousands by filing date
MEI Pharma, Inc.552798202Common10,137,859$41,869,000thousands by filing date
EPIZYME INC29428V104COM2,331,534$37,444,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM1,423,794$34,541,000thousands by filing date
ADC THERAPEUTICS SAH0036K147COMMON STOCK539,648$25,261,000thousands by filing date
TURNING PT THERAPEUTICS90041T108COM308,686$19,938,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock337,291$14,571,000thousands by filing date
MERUS N VN5749R100COM700,879$11,277,000thousands by filing date
AUTOLUS THERAPEUTICS PLC SPON05280R100COM39,740$637,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-20-008310this filing2020-08-12acceptance time not in the bulk data set